edetic acid has been researched along with meglumine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolb, WP; Lang, JH; Lasser, EC | 1 |
| Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
| Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
| Peters, PE; Rummeny, EJ | 1 |
| Elizondo, G; Fretz, CJ; Stark, DD | 1 |
| Golman, K; Holtz, E; Klaveness, J; Leander, P; Leunbach, I; Olsson, M | 1 |
| Braunschweiger, PG; Furmanski, P; Schiffer, L | 1 |
| Chuck, LH; Mathey, D; Parmley, WW; Refsum, H; Rouleau, JL; Sievers, RE | 1 |
| Kopp, AF; Laniado, M | 1 |
| Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V | 1 |
| De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
| Helmberger, T; Semelka, RC | 1 |
| Reimer, P; Schima, W; Schneider, G | 1 |
| Rummeny, EJ; Settles, M; Weirich, G; Wiener, E; Woertler, K | 1 |
| Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK | 1 |
| Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA | 1 |
| Baranyai, Z; Brücher, E; Pálinkás, Z; Rózsa, B | 1 |
| Bains, S; Factor, C; Fretellier, N; Idée, JM; Jestin, G; Johnson, C; MacNeil, S; Morcos, SK | 1 |
| Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
7 review(s) available for edetic acid and meglumine
| Article | Year |
|---|---|
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
[Current status of the clinical development of MR contrast media].
Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Iron; Lymphography; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 1997 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
1 trial(s) available for edetic acid and meglumine
| Article | Year |
|---|---|
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
11 other study(ies) available for edetic acid and meglumine
| Article | Year |
|---|---|
Nonimmunologic complement activation in normal human serum induced by radiographic contrast media.
Topics: Agammaglobulinemia; Complement C2; Complement System Proteins; Contrast Media; Dose-Response Relationship, Immunologic; Edetic Acid; Hemolysis; Humans; Immunoelectrophoresis; Iothalamic Acid; Meglumine; Time Factors | 1978 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Liver-specific contrast agents for MRI.
Topics: Acetates; Animals; Contrast Media; Dextrans; Edetic Acid; Ethylenediamines; Ferrosoferric Oxide; Ferrous Compounds; Iron; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Rats | 1990 |
MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Topics: Animals; Cholestasis; Chromium; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Manganese; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1990 |
The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
Topics: Animals; Chromium Radioisotopes; Contrast Media; Edetic Acid; Extracellular Space; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid | 1986 |
Direct pharmacologic and osmolal effects of contrast media on the mechanics of heart muscle isolated from cats.
Topics: Animals; Calcium; Cats; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Drug Combinations; Edetic Acid; In Vitro Techniques; Meglumine; Metrizamide; Myocardial Contraction; Osmolar Concentration; Papillary Muscles; Sodium; Sucrose | 1984 |
Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents.
Topics: Animals; Arthrography; Cartilage, Articular; Cattle; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Patellar Ligament; Pyridoxal Phosphate; Sodium Chloride; Time Factors | 2007 |
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2009 |
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds | 2010 |
Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand.
Topics: Contrast Media; Edetic Acid; Gadolinium DTPA; Hydrogen-Ion Concentration; Kinetics; Ligands; Magnetic Resonance Imaging; Meglumine; Molecular Structure; Organometallic Compounds | 2011 |
Gadolinium contrast agent associated stimulation of human fibroblast collagen production.
Topics: Chromatography, High Pressure Liquid; Collagen; Colorimetry; Contrast Media; Edetic Acid; Fibroblasts; Gadolinium DTPA; Humans; Keratinocytes; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Skin | 2011 |